Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNIH grant/contract information was added to the study's identifiers, and the page revision tag was updated from v3.6.5 to v3.6.6, reflecting editorial/version updates on the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows an updated revision label, v3.6.5, replacing the previous v3.6.4, indicating a small update to the page's versioning.SummaryDifference0.1%

- Check44 days agoChange DetectedThere are no textual changes detected for this study page. The content appears unchanged.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor update to the page's version metadata without altering the study content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov entry without altering the study data. The study data and eligibility information appear unchanged.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0, indicating a small update to the page build rather than any substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.